These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 3136330)

  • 21. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
    Malone JI; Lowitt S; Corsico N; Orfalian Z
    Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
    Kishi Y; Schmelzer JD; Yao JK; Zollman PJ; Nickander KK; Tritschler HJ; Low PA
    Diabetes; 1999 Oct; 48(10):2045-51. PubMed ID: 10512372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.
    Popp-Snijders C; Lomecky-Janousek MZ; Schouten JA; van der Veen EA
    Diabetologia; 1984 Nov; 27(5):514-6. PubMed ID: 6439588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes.
    Yagihashi S; Wada R; Kamijo M; Nagai K
    Lab Invest; 1993 Mar; 68(3):296-307. PubMed ID: 8383778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorbitol, inositol and nerve conduction in diabetes.
    Gillon KR; Hawthorne JN
    Life Sci; 1983 Apr; 32(17):1943-7. PubMed ID: 6835015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Coleman BD; Williamson JR; Tilton RG
    Diabetes; 1991 May; 40(5):574-82. PubMed ID: 1902427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
    Greene DA; Chakrabarti S; Lattimer SA; Sima AA
    J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
    Greene DA
    Drugs; 1986; 32 Suppl 2():6-14. PubMed ID: 3024950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance.
    Sundkvist G; Dahlin LB; Nilsson H; Eriksson KF; Lindgärde F; Rosén I; Lattimer SA; Sima AA; Sullivan K; Greene DA
    Diabet Med; 2000 Apr; 17(4):259-68. PubMed ID: 10821291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
    Greene DA
    Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor.
    Sima AA; Nathaniel V; Prashar A; Bril V; Greene DA
    Diabetes; 1991 Sep; 40(9):1090-9. PubMed ID: 1936616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
    Berti-Mattera L; Day N; Peterson RG; Eichberg J
    Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
    MacGregor LC; Matschinsky FM
    J Clin Invest; 1985 Aug; 76(2):887-9. PubMed ID: 3928685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats.
    Kato N; Mizuno K; Matsubara A; Nakano K; Kurono M; Yagihashi S
    J Diabetes Complications; 1994; 8(1):27-32. PubMed ID: 8167384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aldose reductase inhibitors on glucose-induced changes in sorbitol and myo-inositol metabolism in human neutrophils.
    Suzuki K; Kawamura T; Sakakibara F; Sasaki H; Sano T; Sakamoto N; Hotta N
    Diabet Med; 1999 Jan; 16(1):67-73. PubMed ID: 10229296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free and lipid inositol, sorbitol and sugars in sciatic nerve obtained post-mortem from diabetic patients and control subjects.
    Mayhew JA; Gillon KR; Hawthorne JN
    Diabetologia; 1983 Jan; 24(1):13-5. PubMed ID: 6825977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.